We are internationally recognized for CHIM expertise. When appropriate and ethically approved, CHIMs can substantially accelerate infectious-disease product development by enabling early, decision-quality read-outs. Curious whether a CHIM fits your program? Please get in touch, we are happy to explore options with you.
Building on decades of experience in early-phase development, we help map the path from candidate to first-in-human and beyond. We prepare for and facilitate interactions with Dutch or European regulators and ethics committees and can provide a clear overview of required work packages, budgets, and timelines.
We are deeply invested in our clients’ success because we understand that life-saving infectious disease products need to reach patients quickly and cost-effectively. Our approach combines rigorous quality standards with an innovative mindset that identifies pragmatic solutions others might overlook. This combination of scientific rigor and strategic thinking has established our reputation for delivering results that matter.
